Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-500-1 | CAS number: 121-82-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: This report is a review of the existing literature about the toxicology of RDX. Limited study summary. Study run to a reliable method but not to GLP and no guideline followed.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- RDX was applied to the clipped backs in doses of 1 or 0.1 mL to 6 rabbits per mixture of RDX/solvent and volume 5 day/week for 4 weeks.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- RDX
- IUPAC Name:
- RDX
- Test material form:
- solid: crystalline
- Details on test material:
- No complementary data available.
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- other: DMSO, acetone, cyclohexanone
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- 5 day/week
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
165 mg/kg/day in DMSO
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
37.5 mg/kg/day in cyclohexanone
Basis:
nominal per unit body weight
- Remarks:
- Doses / Concentrations:
27 mg/kg/day in acetone
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 6 rabbits per dose group
- Control animals:
- yes, concurrent vehicle
Results and discussion
Effect levels
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The repeated doses (daily 5 days/week for 4 weeks) of RDX in DMSO produced no gross evidence of cutaneous irritation throughout the 30 -day observation period. Although no gross effects could be seen, a death occurred after the eighth application of the 1 mL dose of RDX in cyclohexanone (10th day of test), one death after the fifth application of the 0.1 mL dose of RDX in acetone (7th day), and another death after the 10th application of 1 mL dose of RDX in acetone (13th day).
Pathological findings:
Lesion which could be attributed to the compounds tested were confined to the site of application.
When skin was affected, it was often reddened or thickened and there was microscopic evidence of inflammation.
When minimal dermatitis occured in animals that received the mixtures, there was dermatitis of a similar degree in the corresponding solvent control animal, with these exceptions. The animals treated with either 1, 10, or 20 1 mL doses of RDX in DMSO consistently had dermatitis at the time of necropsy while those receiving the same dose of DMSO alone did not. Two rabbits that received one 1 mL dose of RDX in acetone and two that received 20 1 mL doses of RDX in cyclohexanone had dermatitis and the solvent control did not.
No lesions were found in the livers, kidneys, spleens, lungs, tracheas, hearts, intestines, bladders, muscles, bones, or bones marrows of the rabbits which died or were sacrified following repeated topical applications of RDX in the three solvents, or the solvents alone. Gross examination of eyes revealed no cataracts.
When presented for sacrifice and necropsy, three animals had signs of posterior leg weakness or posterior lef paralysis (possibly attributed to broken backs). They had been treated with 5 1 mL doses of RDX (33% in DMSO).
The most serious hazard incident to handling the test solutions appears to be that of repeated skin contact with 5.4% RDX in acetone (2 deaths) and 7.5% RDX in cyclohexanone (1 death).
Applicant's summary and conclusion
- Conclusions:
- According to these results, RDX induce no more damaging than the solvents alone in a repeated dermal exposure in rabbits.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.